Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel artificial intelligence-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable breast cancer screening tool that can be deployed in any primary clinic, hospital or used for outreach programs. The core technology of our solution has been developed using our patented AI / machine learning algorithms for reliable and accurate detection of breast cancer.